The Beauty Health Company (NASDAQ:SKIN) Receives $2.02 Average Target Price from Analysts

The Beauty Health Company (NASDAQ:SKIN) has earned a consensus rating of “Hold” from the eight analysts that are currently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating and one has given a buy rating to the company. The average 1 year target price among brokerages that have covered the stock in the last year is $2.02.

A number of research firms have commented on SKIN. Canaccord Genuity Group lowered their target price on shares of Beauty Health from $1.50 to $1.00 and set a “hold” rating for the company in a report on Friday, May 1st. Roth Mkm reaffirmed a “buy” rating and set a $2.00 target price (down from $2.50) on shares of Beauty Health in a report on Wednesday, May 20th. TD Cowen lowered their target price on shares of Beauty Health from $1.65 to $1.50 and set a “hold” rating for the company in a report on Monday, March 16th. Zacks Research raised shares of Beauty Health from a “strong sell” rating to a “hold” rating in a report on Monday, March 16th. Finally, Benchmark reaffirmed a “hold” rating on shares of Beauty Health in a report on Friday, March 13th.

Institutional Trading of Beauty Health

A number of institutional investors have recently bought and sold shares of the business. Capricorn Fund Managers Ltd acquired a new stake in Beauty Health during the 1st quarter worth $17,270,000. Mirabella Financial Services LLP grew its holdings in Beauty Health by 21.3% during the 3rd quarter. Mirabella Financial Services LLP now owns 15,596,277 shares of the company’s stock worth $31,037,000 after acquiring an additional 2,734,728 shares during the period. Woodline Partners LP grew its holdings in Beauty Health by 255.9% during the 3rd quarter. Woodline Partners LP now owns 5,930,027 shares of the company’s stock worth $11,801,000 after acquiring an additional 4,263,997 shares during the period. Millennium Management LLC grew its holdings in Beauty Health by 127.0% during the 4th quarter. Millennium Management LLC now owns 5,764,802 shares of the company’s stock worth $8,013,000 after acquiring an additional 3,225,668 shares during the period. Finally, Geode Capital Management LLC grew its holdings in shares of Beauty Health by 27.5% in the 2nd quarter. Geode Capital Management LLC now owns 2,302,784 shares of the company’s stock valued at $4,399,000 after buying an additional 496,963 shares during the period. Institutional investors and hedge funds own 93.26% of the company’s stock.

Beauty Health Stock Performance

SKIN stock opened at $0.61 on Friday. The company has a debt-to-equity ratio of 4.37, a current ratio of 1.79 and a quick ratio of 1.48. The company has a 50 day moving average price of $0.81 and a 200 day moving average price of $1.14. Beauty Health has a fifty-two week low of $0.55 and a fifty-two week high of $2.69. The stock has a market capitalization of $79.09 million, a PE ratio of -3.59 and a beta of 1.09.

Beauty Health (NASDAQ:SKIN) last posted its quarterly earnings data on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.09) by $0.04. Beauty Health had a negative net margin of 2.03% and a negative return on equity of 9.38%. The firm had revenue of $64.91 million during the quarter, compared to analysts’ expectations of $66.28 million. Analysts forecast that Beauty Health will post -0.14 EPS for the current year.

Beauty Health Company Profile

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.